Clene Inc. (CLNNW)
0.03
-0.01 (-15.25%)
At close: Apr 21, 2025, 3:00 PM
0.03
3.44%
After-hours: Apr 21, 2025, 07:00 PM EDT
-15.25% (1D)
| Bid | 0.02 |
| Market Cap | 25.34M |
| Revenue (ttm) | n/a |
| Net Income (ttm) | n/a |
| EPS (ttm) | n/a |
| PE Ratio (ttm) | n/a |
| Forward PE | n/a |
| Analyst | n/a |
| Ask | 0.04 |
| Volume | 12,963 |
| Avg. Volume (20D) | 10,800.12 |
| Open | 0.03 |
| Previous Close | 0.04 |
| Day's Range | 0.03 - 0.03 |
| 52-Week Range | 0.03 - 0.03 |
| Beta | 0.46 |
About CLNNW
Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology (CSN) therapeutics. Its lead drug is CNM-Au8, which is being studied in various clinical trials, including a Phase 2/3 registrational clinical trial for patients with amyotrophic lateral sclerosis (ALS); completed Phase 2 proof of concept clinical trial in patients with early symptomatic ALS; com...
Industry Biotechnology
Sector Healthcare
IPO Date n/a
Employees 75
Stock Exchange NASDAQ
Ticker Symbol CLNNW
Website https://clene.com